30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

A Final Look at 2010 Results: TiGenix

TIGENIX
€2.4MM (~US $3.4MM) +135%

ChondroCelect
* 43 patients treated throughout Europe
* Received regulatory clearance and reimbursement in Belgium
* Discussions advancing in other countries (e.g. France, Germany, Netherlands, Spain, U.K.) relative to pricing, reimbursement

ChondroMimetic
* Launched in 9/10 with distribution agreements signed in Europe